HAVCR2 and B-cell chronic lymphocytic leukemia: In this study, we aimed to investigate whether IL-27 stimulation affects the expression of immune checkpoint molecules TIM-3 and Gal-9, thereby elucidating its potential anti-tumour role in CLL.